Current Status of Induction of Specific Unresponsiveness to Organ Allografts
Few, if any, purposeful attempts have been made to induce specific unresponsiveness to organ allografts in man. Nevertheless, there is an enormous experimental literature to show that attempts to induce unresponsiveness of some type in man are a reasonable undertaking. It is the purpose of this chapter to identify the principles and problems in the induction of unresponsiveness to allografts. No attempt will be made to review the enormous literature of this subject. Rather, experimental models developed and studied by our own group will be described to illustrate how clinical attempts for unresponsiveness induction could be undertaken.
KeywordsDonor Bone Marrow Skin Allograft Total Lymphoid Irradiation Organ Allograft Tolerant Mouse
Unable to display preview. Download preview PDF.
- 2.Kaliss N: Dynamics of immunologic enhancement. Transpl Proc 2:59, 1970.Google Scholar
- 4.Hellstrom I, Hellstrom KE: microcytotoxicity assays of cell-mediated tumor immunity and blocking serum factor, in: Bloom BR, Glade PR (eds): In Vitro Methods in Cell-Mediated Immunity. New York, Academic Press, 1976, pp 533–539.Google Scholar
- 6.Wood ML, Monaco AP: Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice. Transpl Proc 10:379, 1978.Google Scholar
- 7.Monaco AP, Wood ML, Lytle B, Barrett I: Studies on heterologous antilymphocyte serum in mice. VI Further studies on tolerance. Colloques Internationaux CNRS 190:361, 1971.Google Scholar
- 8.Monaco AP: Immunological tolerance and enhancement in experimental and clinical renal transplantation, Mexico 1972. Basel Karger, 1974, 5th International Congress Nephrology, in: Proceedings vol. 1, pp 99–109.Google Scholar
- 9.Wood ML, Heppner G., Gozzo JJ, Monaco AP: Mechanisms of augmented graft survival in mice after ALS and bone marrow infusion. Transpl Proc 5:691, 1973.Google Scholar
- 10.Monaco AP, Gozzo JJ, Wood ML, Liegeois A: Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): Tolerance by intraorgan injection. Transpl Proc 3:680, 1971.Google Scholar
- 11.Wood ML, Monaco AP, Gozzo JJ, Liegeois A: Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing. Transpl Proc 3:676, 1971.Google Scholar
- 12.Gozzo JJ, Litvin DA, Monaco AP, Bhatnager YM: Fractionated bone marrow: Use of a lymphocyte containing fraction for skin allograft prolongation in ALS treated mice. Transpl Proc 13:592, 1981.Google Scholar
- 13.Caridis DT, Liegeois A, Barrett I, Monaco AP: Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transpl Proc 5:671, 1973.Google Scholar
- 14.Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Ann Surg 79:384, 1976.Google Scholar
- 15.Strober S, Slavin S, Fuks Z, Kaplan HS, Gottlieb M. Bieber C, Hoppe RT, Grumet FC: Transplantation tolerance after total lymphoid irradiation. Proc 11:1032, 1979.Google Scholar